Atlas Trials

Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)

Clinical trial NCT05203224 · COMPLETED

Trial details

NCT number
NCT05203224
Sponsor
University of Melbourne
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ischemic Stroke
Start date
2022-02-18
Primary completion
2025-11-24
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.